These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 29222040)
1. Prohibitin: A new player in immunometabolism and in linking obesity and inflammation with cancer. Zi Xu YX; Ande SR; Mishra S Cancer Lett; 2018 Feb; 415():208-216. PubMed ID: 29222040 [TBL] [Abstract][Full Text] [Related]
2. Prohibitin - At the crossroads of obesity-linked diabetes and cancer. Mishra S; Nyomba BG Exp Biol Med (Maywood); 2017 Jun; 242(11):1170-1177. PubMed ID: 28399645 [TBL] [Abstract][Full Text] [Related]
3. Prohibitin: a prime candidate for a pleiotropic effector that mediates sex differences in obesity, insulin resistance, and metabolic dysregulation. Xu YXZ; Bassi G; Mishra S Biol Sex Differ; 2019 May; 10(1):25. PubMed ID: 31118075 [TBL] [Abstract][Full Text] [Related]
4. Prohibitin in Adipose and Immune Functions. Ande SR; Nguyen KH; Nyomba BLG; Mishra S Trends Endocrinol Metab; 2016 Aug; 27(8):531-541. PubMed ID: 27312736 [TBL] [Abstract][Full Text] [Related]
5. Prohibitin plays a role in the functional plasticity of macrophages. Xu YXZ; Ande SR; Ikeogu NM; Zhou K; Uzonna JE; Mishra S Mol Immunol; 2022 Apr; 144():152-165. PubMed ID: 35219912 [TBL] [Abstract][Full Text] [Related]
6. Expression of a mutant prohibitin from the aP2 gene promoter leads to obesity-linked tumor development in insulin resistance-dependent manner. Ande SR; Nguyen KH; Padilla-Meier GP; Nyomba BL; Mishra S Oncogene; 2016 Aug; 35(34):4459-70. PubMed ID: 26751773 [TBL] [Abstract][Full Text] [Related]
7. Prohibitin: A hypothetical target for sex-based new therapeutics for metabolic and immune diseases. Mishra S; Nyomba BG Exp Biol Med (Maywood); 2019 Feb; 244(2):157-170. PubMed ID: 30717609 [TBL] [Abstract][Full Text] [Related]
8. Prohibitin: an unexpected role in sex dimorphic functions. Nguyen KH; Ande SR; Mishra S Biol Sex Differ; 2016; 7():30. PubMed ID: 27347368 [TBL] [Abstract][Full Text] [Related]
9. Effect of estrogen on expression of prohibitin in white adipose tissue and liver of diet-induced obese rats. Choi M; Chaudhari HN; Ji YR; Ryoo ZY; Kim SW; Yun JW Mol Cell Biochem; 2015 Sep; 407(1-2):181-96. PubMed ID: 26048717 [TBL] [Abstract][Full Text] [Related]
10. Prohibitin: a potential target for new therapeutics. Mishra S; Murphy LC; Nyomba BL; Murphy LJ Trends Mol Med; 2005 Apr; 11(4):192-7. PubMed ID: 15823758 [TBL] [Abstract][Full Text] [Related]
11. Cellular Mechanisms Driving Sex Differences in Adipose Tissue Biology and Body Shape in Humans and Mouse Models. Karastergiou K; Fried SK Adv Exp Med Biol; 2017; 1043():29-51. PubMed ID: 29224089 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial metabolism, reactive oxygen species, and macrophage function-fishing for insights. Hall CJ; Sanderson LE; Crosier KE; Crosier PS J Mol Med (Berl); 2014 Nov; 92(11):1119-28. PubMed ID: 24957262 [TBL] [Abstract][Full Text] [Related]
16. Macrophage recruitment in obese adipose tissue. Bai Y; Sun Q Obes Rev; 2015 Feb; 16(2):127-36. PubMed ID: 25586506 [TBL] [Abstract][Full Text] [Related]
17. Signaling pathways of prohibitin and its role in diseases. Zhou TB; Qin YH J Recept Signal Transduct Res; 2013; 33(1):28-36. PubMed ID: 23327602 [TBL] [Abstract][Full Text] [Related]
18. Adipocytes properties and crosstalk with immune system in obesity-related inflammation. Maurizi G; Della Guardia L; Maurizi A; Poloni A J Cell Physiol; 2018 Jan; 233(1):88-97. PubMed ID: 28181253 [TBL] [Abstract][Full Text] [Related]
19. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ. Calabro P; Yeh ET Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046 [TBL] [Abstract][Full Text] [Related]
20. Sex Differences in Immunometabolism: An Unexplored Area. Mishra S; Bassi G; Xu YXZ Methods Mol Biol; 2020; 2184():265-271. PubMed ID: 32808231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]